Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $59.8 in the prior trading day, Nutrien Ltd (NYSE: NTR) closed at $59.82, up 0.03%. In other words, the price has increased by $0.03 from its previous closing price. On the day, 2.65 million shares were traded. NTR stock price reached its highest trading level at $61.15 during the session, while it also had its lowest trading level at $59.7.
Ratios:
Our goal is to gain a better understanding of NTR by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 46.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.85. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.43.
On October 14, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $67.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 29134708736 and an Enterprise Value of 42505433088. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.12, and their Forward P/E ratio for the next fiscal year is 12.75. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.09 while its Price-to-Book (P/B) ratio in mrq is 1.15. Its current Enterprise Value per Revenue stands at 1.656 whereas that against EBITDA is 8.155.
Stock Price History:
The Beta on a monthly basis for NTR is 0.75, which has changed by 0.1683594 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, NTR has reached a high of $65.08, while it has fallen to a 52-week low of $45.78. The 50-Day Moving Average of the stock is 0.98%, while the 200-Day Moving Average is calculated to be 3.44%.
Shares Statistics:
The stock has traded on average 2.44M shares per day over the past 3-months and 2298940 shares per day over the last 10 days, according to various share statistics. A total of 484.33M shares are outstanding, with a floating share count of 483.02M. Insiders hold about 0.07% of the company’s shares, while institutions hold 75.02% stake in the company. Shares short for NTR as of 1765756800 were 12124530 with a Short Ratio of 4.98, compared to 1763078400 on 4489477. Therefore, it implies a Short% of Shares Outstanding of 12124530 and a Short% of Float of 2.5100000000000002.
Dividends & Splits
In the trailing 12 months, NTR’s forward annual dividend rate was 2.175, compared to 2.18 this year. Against a Trailing Annual Dividend Yield of 0.035018515. The stock’s 5-year Average Dividend Yield is 3.31.
Earnings Estimates
. The current market rating for Nutrien Ltd (NTR) reflects the collective analysis of 14.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.51, with high estimates of $0.77 and low estimates of $0.12.
Analysts are recommending an EPS of between $4.86 and $4.13 for the fiscal current year, implying an average EPS of $4.62. EPS for the following year is $4.65, with 21.0 analysts recommending between $5.85 and $3.95.
Revenue Estimates
6 analysts predict $5.25B in revenue. The current quarter. It ranges from a high estimate of $5.37B to a low estimate of $5.09B. As of. The current estimate, Nutrien Ltd’s year-ago sales were $4.86BFor the next quarter, 6 analysts are estimating revenue of $5.19B. There is a high estimate of $5.29B for the next quarter, whereas the lowest estimate is $5.07B.
A total of 15 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $27.62B, while the lowest revenue estimate was $25.9B, resulting in an average revenue estimate of $26.4B. In the same quarter a year ago, actual revenue was $25.02BBased on 15 analysts’ estimates, the company’s revenue will be $26.63B in the next fiscal year. The high estimate is $27.73B and the low estimate is $25.68B.
